StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$13.07+0.57 (+4.56%)

Close on Nov 18, 2026Market cap $142.28MP/E –Yield –

Burning Rock Biotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -CN¥54.85M. The highest annual figure on record is -CN¥54.85M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CN¥54.85M–
FY2024Dec 31, 2024-CN¥357.56M–
FY2023Dec 31, 2023-CN¥669.32M–
FY2022Dec 31, 2022-CN¥980.41M–
FY2021Dec 31, 2021-CN¥797.06M–
FY2020Dec 31, 2020-CN¥412.41M–
FY2019Dec 31, 2019-CN¥169.09M–
FY2018Dec 31, 2018-CN¥161.40M–

More Burning Rock Biotech figures

See a number that looks wrong?